LAS VEGAS (MedPage Today) -- Riluzole (Rilutek) should remain on the Veterans Administration formulary as a treatment for patients with amyotrophic lateral sclerosis, despite having only modest benefits and considerable cost, a researcher said here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment